超声剪切波弹性成像测量的肝脏硬度与Fontan循环患者门静脉高压及循环衰竭的相关性
这项回顾性研究纳入119例10岁及以上Fontan循环患者,首次肝脏超声二维剪切波弹性成像测得中位肝脏硬度2.22 m/s;初始肝脏硬度较高与随访期门静脉高压(VAST评分≥1)及Fontan循环衰竭相关,预测AUC分别为0.70和0.74(敏感度79%/84%,特异度57%/52%)。作者认为超声剪切波弹性成像可能在Fontan术后监测中发挥作用。
要点
- Fontan循环患者初始肝脏硬度中位2.22 m/s,随访VAST评分较初始升高(中位0升至1,p=.004)。
- 随访VAST评分≥1者初始肝脏硬度2.37 m/s,高于评分为0者的2.08 m/s(p=.005)。
- 发生Fontan循环衰竭者初始肝脏硬度2.43 m/s,高于未发生者的2.10 m/s(p<.001)。
核心结论
- Fontan循环患者初始肝脏硬度升高与随访期门静脉高压和循环衰竭相关,但预测效能中等。
研究设计与样本
- 回顾性研究纳入119例10岁及以上Fontan循环患者(中位年龄19.1岁;女61例、男58例),2015年1月1日至2022年1月1日行肝脏超声二维剪切波弹性成像,并有1年及以上临床随访(除非更早发生结局相关事件)。
- 记录首次超声检查的中位肝脏硬度,以VAST评分(范围0-4)作为门静脉高压标志,于初次超声及1年及以上随访影像(超声、CT或MRI)中判定。
关键影像表现/征象
- 首次超声中位肝脏硬度为2.22 m/s。
- 初始VAST评分中位0(IQR 0-1),随访VAST评分中位1(IQR 0-2)(p=.004)。
诊断标准与关键数值
- 初始肝脏硬度预测随访VAST评分≥1:AUC 0.70,敏感度79%,特异度57%,阈值>2.11 m/s。
- 初始肝脏硬度预测Fontan循环衰竭:AUC 0.74,敏感度84%,特异度52%,阈值>2.12 m/s。
- 初始肝脏硬度是Fontan循环衰竭唯一显著的独立预测因子(OR=3.76;p<.001);年龄、性别、Fontan手术类型、优势心室形态及初始VAST评分均非独立预测因子。
临床应用与阅片要点
- 作者认为超声剪切波弹性成像可能在Fontan术后监测中发挥作用,支持个体化的内科和外科诊疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. The Fontan operation palliates single-ventricle congenital heart disease but causes hepatic congestion with associated progressive hepatic fibrosis. OBJECTIVE. The purpose of this study was to evaluate associations between liver stiffness measured using ultrasound (US) shear-wave elastography (SWE) in patients with Fontan palliation and the occurrence of portal hypertension and Fontan circulatory failure during follow-up. METHODS. This retrospective study included 119 individuals 10 years old or older (median age, 19.1 years; 61 female patients, 58 male patients) with Fontan circulation who underwent liver US with 2D SWE from January 1, 2015, to January 1, 2022, and had 1 year or more of clinical follow-up (unless experiencing earlier outcome-related events). Median liver stiffness from the initial US examination was documented. Varices, ascites, splenomegaly, and thrombocytopenia (VAST) scores (range, 0-4) were determined as a marker of portal hypertension on initial US examination and 1 year or more of follow-up imaging (US, CT, or MRI). Composite clinical outcome for Fontan circulatory failure (death, mechanical circulatory support, cardiac transplant, or unexpected Fontan circulation-related hospitalization) was assessed. Analysis included the Wilcoxon rank sum test, logistic regression analysis with stepwise variable selection, and ROC analysis. RESULTS. Median initial liver stiffness was 2.22 m/s. Median initial VAST score was 0 (IQR, 0-1); median follow-up VAST score was 1 (IQR, 0-2) (p = .004). Fontan circulatory failure occurred in 37 of 119 (31%) patients (median follow-up, 3.4 years). Initial liver stiffness was higher in patients with a follow-up VAST score of 1 or greater (2.37 m/s) than in those with a follow-up VAST score of 0 (2.08 m/s) (p = .005), and initial liver stiffness was higher in patients with (2.43 m/s) than without (2.10 m/s) Fontan circulatory failure during follow-up (p < .001). Initial liver stiffness was the only significant independent predictor of Fontan circulatory failure (OR = 3.76; p < .001); age, sex, Fontan operation type, dominant ventricular morphology, and initial VAST score were not independent predictors. Initial liver stiffness had an AUC of 0.70 (sensitivity, 79%; specificity, 57%; threshold, > 2.11 m/s) for predicting a follow-up VAST score of 1 or greater and an AUC of 0.74 (sensitivity, 84%; specificity, 52%; threshold, > 2.12 m/s) for predicting Fontan circulatory failure. CONCLUSION. In patients with Fontan circulation, increased initial liver stiffness was associated with portal hypertension and circulatory failure during follow-up, although it had moderate performance in predicting these outcomes. CLINICAL IMPACT. US SWE may play a role in post-Fontan surveillance, supporting tailored medical and surgical care.
引用
- Derinkuyu BE, Dillman JR, Lubert AM, et al. Associations of Liver Stiffness Measured by Ultrasound Shear-Wave Elastography With Portal Hypertension and Circulatory Failure in Individuals With Fontan Circulation. AJR Am J Roentgenol. 2023. PMID: 37530396. doi:10.2214/AJR.23.29640
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。